Monitoring device tested in severe kidney and heart failure
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure that is severe (NYHA class III) and were hospitalized for worsening heart function in the past year
- You have severe kidney impairment for at least 3 months (a measured low kidney filtration rate)
- Your heart’s right-side pressure assessment is concerning: your right-heart echo measure is low (TAPSE under 15 mm) and/or another measure is low (SDTI under 9.5 cm/s)
- You have a wide enough blood vessel for the procedure: your pulmonary artery is over 7 mm (and no blood vessel is too small)
- You must be able to give consent and tolerate the right-heart catheter procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.